Literature DB >> 1937323

[Diagnosis of Lyme neuroborreliosis. Detection of intrathecal antibody formation].

B Wilske1, L Bader, H W Pfister, V Preac-Mursic.   

Abstract

The most common neurological manifestation of Lyme disease is lymphocytic meningoradiculitis (Banwarth's syndrome, stage II). In rare cases, chronic progressive encephalomyelitis (stage III) with symptoms similar to multiple sclerosis is observed. Antibodies against Borrelia burgdorferi are detectable in 70-90% of stage II cases, with IgM-antibodies predominating in the first two weeks, and IgG-antibodies thereafter. Detection of specific intrathecal antibodies is the best serodiagnostic parameter for diagnosing neuroborreliosis. With the aid of a CSF/serum index determination (on the basis of a comparison of IgG-antibody ELISA titers in CSF and serum with identical IgG concentrations) involvement of the nervous system was shown in 64% and 77%, respectively, of 76 stage II cases (diagnostic significance 98% and 100%, respectively). In particular when tertiary forms of the disease are suspected immunoblot techniques (Western blot, IEF-affinity blot) are recommended confirmatory tests.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937323

Source DB:  PubMed          Journal:  Fortschr Med        ISSN: 0015-8178


  6 in total

1.  Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe.

Authors:  U Hauser; G Lehnert; B Wilske
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato.

Authors:  U Hauser; H Krahl; H Peters; V Fingerle; B Wilske
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato.

Authors:  U Hauser; G Lehnert; R Lobentanzer; B Wilske
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

4.  Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato.

Authors:  B Wilske; V Fingerle; V Preac-Mursic; S Jauris-Heipke; A Hofmann; H Loy; H W Pfister; D Rössler; E Soutschek
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

5.  Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay.

Authors:  B Wilske; V Fingerle; P Herzer; A Hofmann; G Lehnert; H Peters; H W Pfister; V Preac-Mursic; E Soutschek; K Weber
Journal:  Med Microbiol Immunol       Date:  1993-11       Impact factor: 3.402

6.  Diagnostic value of proteins of three Borrelia species (Borrelia burgdorferi sensu lato) and implications for development and use of recombinant antigens for serodiagnosis of Lyme borreliosis in Europe.

Authors:  U Hauser; G Lehnert; B Wilske
Journal:  Clin Diagn Lab Immunol       Date:  1998-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.